Fibromyalgia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older.
- You must not be planning any changes to your medications or treatments in the next 3 months.
- You must be willing and able to have an MRI scan.
- You must not feel afraid of enclosed spaces (claustrophobia).
- You must be alert, aware of your surroundings, and able to give your consent to take part.
- You must be able to speak and read English.
For people with chronic widespread pain/fibromyalgia only:
- You must score at a certain level on standard fibromyalgia questionnaires that measure how widespread your pain is and how severely it affects you (confirm with trial site).
- Your pain must have been present for at least 3 months.
- Your pain must affect at least 4 out of 5 areas of the body.
- Your average pain level over the past month must be at least 4 out of 10.
For people with a specific eye condition called Congenital Stationary Night Blindness only:
- 2 participants who have been diagnosed with this inherited night vision condition and do not have chronic widespread pain are also being recruited.
Who may not be able to join:
- You have a condition that affects your retina or causes vision impairment.
- You experience sensitivity to light or discomfort around light (for example, as seen in some autoimmune conditions like lupus).
- You have uveitis, cataracts, colour blindness, or a history of seizures.
- You are planning any changes to pain treatments in the next 3 months, such as surgery, new medications, injections, or other pain procedures.
- You are currently imprisoned.
- You are pregnant.
- You have anything in or on your body that makes an MRI unsafe, such as certain metal implants or medical devices that are not MRI-compatible.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Matthew Mauck, MD, PhD, University of North Carolina, Chapel Hill
Phone: 919-966-5136
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Resting State Functional Connectivity-seed Voxel Analysis in Participants with cMSP and Healthy Controls; Whole Brain Evoked Activation Patterns in Response to Chromatic Stimuli Contrasted with Achromatic Stimuli in Participants with cMSP and Healthy Controls; Whole Brain Evoked Activation Patterns in Response to Chromatic Stimuli Contrasted with Achromatic Stimuli in Patients with cMSP and Healthy Controls Exposed to a Pressure Pain Stimulus
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.